+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Surgical Hemostatic Material Market - Global Forecast 2026-2032- Product Image
Surgical Hemostatic Material Market - Global Forecast 2026-2032- Product Image
New

Surgical Hemostatic Material Market - Global Forecast 2026-2032

  • Report

  • 181 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6279324
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Surgical Hemostatic Materials: Executive Overview

Surgical hemostatic materials are products used to control bleeding during operative and interventional procedures when conventional techniques such as suturing, ligation, cautery, or compression are insufficient or impractical. The category includes absorbable and nonabsorbable materials, topical agents, sealants, and adjunctive technologies. Demand is shaped by procedure volumes, surgical complexity, trauma care, minimally invasive techniques, clinical evidence, regulatory requirements, hospital purchasing practices, and the need to reduce avoidable complications.

Clinical selection depends on bleeding severity, anatomical site, tissue compatibility, time to hemostasis, absorbability, ease of application, infection considerations, and total treatment cost. Product differentiation increasingly centers on predictable performance, handling characteristics, storage requirements, and compatibility with specialized surgical workflows rather than on a single universal solution.

How Surgical Hemostasis Is Evolving Across Care Settings

The landscape is shifting from basic topical control toward procedure-specific hemostatic strategies that combine mechanical, biologic, and energy-based approaches. Surgeons and hospitals increasingly evaluate products according to the complete workflow: preparation, application, control of bleeding, removal or absorption, postoperative monitoring, and documentation. This favors solutions that are easy to deploy, reduce operative disruption, and support standardized protocols.

Minimally invasive and robotic procedures are also influencing product design. Limited access can make conventional compression and suturing more difficult, increasing the value of applicators, flexible formats, and materials that function in confined or difficult-to-reach sites. At the same time, heightened attention to antimicrobial stewardship, biocompatibility, waste reduction, and supply continuity is affecting procurement and operating-room practice.

Artificial Intelligence Is Strengthening Hemostasis Planning and Evidence Generation

Artificial intelligence is contributing most directly through imaging, workflow analytics, clinical decision support, and research. Computer vision can assist with identifying bleeding sites, characterizing tissue conditions, and reviewing procedural video, while predictive models may help clinicians anticipate patients or procedures with elevated bleeding risk. These applications remain dependent on representative datasets, prospective validation, cybersecurity, clinician oversight, and clear accountability.

AI can also improve product development and post-market surveillance by identifying patterns in adverse-event reports, surgical outcomes, and device performance. Manufacturers and health systems should treat AI as a decision-support capability rather than a substitute for clinical judgment. Effective implementation requires explainable outputs, validated performance across demographic and procedural groups, privacy safeguards, and integration with existing operating-room systems.

Regional Insights: Diverse Surgical Systems Shape Adoption Priorities

North America is characterized by advanced hospital infrastructure, extensive specialist care, and strong emphasis on clinical evidence, reimbursement, patient safety, and operating-room efficiency. Europe combines sophisticated healthcare systems with varied national procurement processes and regulatory expectations, making comparative clinical value and sustainability increasingly important. Asia-Pacific includes highly developed surgical markets alongside rapidly expanding healthcare capacity, creating demand for both premium procedure-specific solutions and dependable products suited to diverse resource settings.

Latin America is influenced by uneven access to specialist surgery, public and private procurement differences, and the need for cost-conscious products with reliable distribution. The Middle East is supported by investment in tertiary hospitals and specialized care, while purchasing can depend on centralized systems, international standards, and local partnerships. Africa presents varied infrastructure and workforce conditions; adoption priorities often include affordability, availability, training, shelf stability, and suitability for emergency and essential surgical care.

Group Insights: Trade, Regulation, and Clinical Cooperation Matter

ASEAN’s heterogeneous healthcare systems create opportunities for products supported by adaptable training, regional distribution, and documentation that can satisfy differing regulatory and procurement requirements. BRICS economies span major surgical centers and resource-constrained settings, making local manufacturing capability, resilient supply chains, and tiered product portfolios strategically relevant. The European Union places strong weight on regulatory compliance, safety documentation, health technology assessment, and environmental considerations across integrated but nationally administered health systems.

G7 markets generally emphasize advanced clinical evidence, quality systems, specialized surgery, and value-based procurement. GCC countries are expanding high-acuity and elective surgical capacity, with priorities that include reliable imports, local service capability, and workforce development. NATO members represent a broad set of health systems and emergency-preparedness environments; suppliers may benefit from robust logistics, interoperability, and products suitable for both routine and trauma-related care, subject to national procurement rules.

Country Insights: Distinct Health-System Conditions Guide Product Strategy

Australia, Canada, the United Kingdom, and the United States combine sophisticated surgical services with scrutiny of evidence, safety, procurement value, and supply reliability. France, Germany, Italy, and Spain operate within the European regulatory environment while retaining distinct reimbursement, hospital purchasing, and clinical practice patterns. These markets reward strong documentation, procedure-specific education, and demonstrable workflow or outcome benefits.

China and India have large and diverse healthcare ecosystems, with simultaneous demand for advanced tertiary-care products, broader hospital access, local production, and cost-sensitive offerings. Japan and South Korea emphasize quality, precision, technology integration, and rigorous clinical use. Brazil and Mexico present opportunities linked to private hospitals, public-sector needs, and regional distribution, but product access can be affected by regulatory processes, affordability, logistics, and differences between urban and underserved care settings. Russia’s operating environment is shaped by regulatory, procurement, and supply-chain conditions that require careful local assessment.

Actions for Leaders: Build Evidence, Resilience, and Procedure-Specific Value

Industry leaders should segment portfolios by bleeding scenario, surgical specialty, care setting, and resource availability rather than rely on a single broad positioning. Evidence programs should connect time to hemostasis, rebleeding, transfusion requirements, complications, operating-room efficiency, and patient-reported or recovery outcomes to the procedures in which products are used. Training should cover selection, application, contraindications, storage, disposal, and escalation when initial control is inadequate.

Commercial and operational priorities should include diversified sourcing, regional inventory strategies, transparent quality systems, and regulatory planning tailored to each jurisdiction. Partnerships with hospitals and professional societies can support protocol development and real-world evaluation. Leaders should also establish disciplined AI governance, monitor post-market signals, assess environmental impacts across the product lifecycle, and communicate economic value in terms that procurement and clinical stakeholders can independently verify.

Research Methodology: Evidence-Led Assessment of a Specialized Surgical Category

This executive summary uses a structured secondary-research framework focused on the clinical, technological, regulatory, operational, and geographic dimensions of surgical hemostatic materials. Relevant evidence should be triangulated across peer-reviewed literature, clinical guidelines, regulatory publications, health-system and procurement documents, public health statistics, procedure trends, safety communications, and validated industry disclosures. Findings should be screened for methodological quality, recency, geographic relevance, and consistency of definitions.

Regional, group, and country interpretation requires contextual comparison rather than direct aggregation. The assessment considers healthcare capacity, surgical practice, reimbursement, procurement, logistics, regulation, workforce capability, and technology adoption. Where evidence is limited or heterogeneous, conclusions should be presented as directional and qualified. Company-specific claims, unsupported estimates, and unverified statements should be excluded from the final analysis.

Conclusion: Reliable Hemostasis Depends on Clinical Fit and System Readiness

Surgical hemostatic materials remain important adjuncts to safe and efficient operative care, but successful adoption depends on more than product availability. Clinical performance, ease of use, patient compatibility, evidence quality, training, procurement value, and dependable supply must align with the needs of each procedure and health system. Regional and country differences make flexible implementation essential.

The strongest strategies will combine procedure-specific innovation with rigorous validation, responsible digital integration, resilient operations, and practical education. Organizations that demonstrate measurable clinical and workflow value while meeting regulatory, sustainability, and access expectations will be better positioned to support surgeons and patients across diverse surgical environments.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Surgical Hemostatic Material Market, by Product Type
7.1. Introduction
7.2. Active Hemostats
7.2.1. Fibrin Based
7.2.2. Recombinant Thrombin
7.2.3. Thrombin Based
7.3. Flowable Hemostats
7.4. Hemostatic Dressings And Bandages
7.5. Passive Hemostats
7.5.1. Chitosan Based
7.5.2. Collagen Hemostat
7.5.3. Gelatin Sponge
7.5.4. Microporous Polysaccharide Hemospheres
7.5.5. Oxidized Regenerated Cellulose
7.6. Sealants And Adhesives
7.6.1. Cyanoacrylate Adhesive
7.6.2. Fibrin Sealant
7.6.3. Polyethylene Glycol Sealant
7.6.4. Synthetic Sealant
7.7. Topical Hemostatic Powders
8. Surgical Hemostatic Material Market, by Composition
8.1. Introduction
8.2. Biological Components
8.2.1. Fibrinogen/Fibrin
8.2.2. Thrombin
8.3. Combination Products
8.4. Natural Polymers
8.4.1. Chitosan
8.4.2. Collagen
8.4.3. Gelatin
8.4.4. Oxidized Regenerated Cellulose
8.4.5. Polysaccharide
8.5. Synthetic Polymers
8.5.1. Cyanoacrylate
8.5.2. Polyethylene Glycol
8.5.3. Polyurethane
9. Surgical Hemostatic Material Market, by Form
9.1. Introduction
9.2. Foam
9.3. Injectable Flowable
9.4. Patch Gel And Film
9.4.1. Film
9.4.2. Patch
9.5. Powder
9.5.1. Ready To Use
9.5.2. Requires Preparation Or Activation
9.6. Sponge
9.6.1. Ready To Use
9.6.2. Requires Preparation Or Activation
9.7. Spray
10. Surgical Hemostatic Material Market, by Mode Of Action
10.1. Introduction
10.2. Active Coagulation Promotion
10.3. Adsorption And Platelet Concentration
10.4. Chemical Hemostatic Reaction
10.5. Mechanical Tamponade
10.6. Sealant And Barrier Formation
11. Surgical Hemostatic Material Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Clinics And Outpatient Facilities
11.4. Dental Clinics
11.5. Hospitals
11.5.1. Emergency And Trauma Centers
11.5.2. Interventional Suites
11.5.3. Operating Rooms
11.6. Military And Field Hospitals
11.7. Specialty Surgical Centers
12. Surgical Hemostatic Material Market, by Application
12.1. Introduction
12.2. Cardiovascular Surgery
12.2.1. Cardiac Surgery
12.2.2. Vascular Surgery
12.3. Dental Procedures
12.4. General Surgery
12.5. Gynecology
12.6. Interventional And Endovascular Procedures
12.7. Minimally Invasive And Laparoscopic Procedures
12.8. Neurosurgery
12.9. Ophthalmic Surgery
12.10. Orthopedic Surgery
12.10.1. Joint Replacement
12.10.2. Spine Surgery
12.11. Otolaryngology
12.12. Plastic And Reconstructive Surgery
12.13. Trauma And Emergency Surgery
12.14. Urology
13. Surgical Hemostatic Material Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Surgical Hemostatic Material Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Surgical Hemostatic Material Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Aegis Lifesciences Private Limited
17.2. B. Braun Melsungen AG
17.3. Baxter International Inc.
17.4. Becton, Dickinson and Company
17.5. CryoLife, Inc.
17.6. Ferrosan Medical Devices A/S
17.7. Hangzhou Singclean Medical Products Co., Ltd.
17.8. Integra LifeSciences Holdings Corporation
17.9. Johnson & Johnson
17.10. Medtronic plc
17.11. Smith & Nephew plc
17.12. Stryker Corporation
17.13. Takeda Pharmaceutical Company Limited
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Surgical Hemostatic Material Market, Years Considered for the Study
FIGURE 2. Global Surgical Hemostatic Material Market, Research Design
FIGURE 3. Global Surgical Hemostatic Material Market, Research Framework
FIGURE 4. Global Surgical Hemostatic Material Market, Data Triangulation
FIGURE 5. Global Surgical Hemostatic Material Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Surgical Hemostatic Material Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Surgical Hemostatic Material Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Surgical Hemostatic Material Market Size, by Composition, 2025 vs 2032 (%)
FIGURE 9. Global Surgical Hemostatic Material Market Size, by Composition, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Surgical Hemostatic Material Market Size, by Form, 2025 vs 2032 (%)
FIGURE 11. Global Surgical Hemostatic Material Market Size, by Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Surgical Hemostatic Material Market Size, by Mode Of Action, 2025 vs 2032 (%)
FIGURE 13. Global Surgical Hemostatic Material Market Size, by Mode Of Action, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Surgical Hemostatic Material Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Surgical Hemostatic Material Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Surgical Hemostatic Material Market Size, by Application, 2025 vs 2032 (%)
FIGURE 17. Global Surgical Hemostatic Material Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Surgical Hemostatic Material Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Surgical Hemostatic Material Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Surgical Hemostatic Material Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Surgical Hemostatic Material Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Surgical Hemostatic Material Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Surgical Hemostatic Material Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Surgical Hemostatic Material Market Segmentation & Coverage
TABLE 2. Global Surgical Hemostatic Material Market Size, 2017-2032 (USD Million)
TABLE 3. Global Surgical Hemostatic Material Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Active Hemostats Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Active Hemostats Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Active Hemostats Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Fibrin Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Fibrin Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Fibrin Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Recombinant Thrombin Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Recombinant Thrombin Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Recombinant Thrombin Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Thrombin Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Thrombin Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Thrombin Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Flowable Hemostats Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Flowable Hemostats Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Flowable Hemostats Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Hemostatic Dressings And Bandages Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Hemostatic Dressings And Bandages Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Hemostatic Dressings And Bandages Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Passive Hemostats Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Passive Hemostats Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Passive Hemostats Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Chitosan Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Chitosan Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Chitosan Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Collagen Hemostat Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Collagen Hemostat Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Collagen Hemostat Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Gelatin Sponge Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Gelatin Sponge Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Gelatin Sponge Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Microporous Polysaccharide Hemospheres Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Microporous Polysaccharide Hemospheres Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Microporous Polysaccharide Hemospheres Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Oxidized Regenerated Cellulose Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Oxidized Regenerated Cellulose Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Oxidized Regenerated Cellulose Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Sealants And Adhesives Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Sealants And Adhesives Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Sealants And Adhesives Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Cyanoacrylate Adhesive Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Cyanoacrylate Adhesive Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Cyanoacrylate Adhesive Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Fibrin Sealant Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Fibrin Sealant Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Fibrin Sealant Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Polyethylene Glycol Sealant Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Polyethylene Glycol Sealant Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Polyethylene Glycol Sealant Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Synthetic Sealant Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Synthetic Sealant Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Synthetic Sealant Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Topical Hemostatic Powders Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Topical Hemostatic Powders Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Topical Hemostatic Powders Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Surgical Hemostatic Material Market Size, by Composition, 2017-2032 (USD Million)
TABLE 59. Global Biological Components Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Biological Components Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Biological Components Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Fibrinogen/Fibrin Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Fibrinogen/Fibrin Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Fibrinogen/Fibrin Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Thrombin Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Thrombin Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Thrombin Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Combination Products Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Combination Products Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Combination Products Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Natural Polymers Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Natural Polymers Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Natural Polymers Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Chitosan Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Chitosan Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Chitosan Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Collagen Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Collagen Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Collagen Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Gelatin Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Gelatin Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Gelatin Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Oxidized Regenerated Cellulose Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Oxidized Regenerated Cellulose Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Oxidized Regenerated Cellulose Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Polysaccharide Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Polysaccharide Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Polysaccharide Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Synthetic Polymers Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global Synthetic Polymers Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global Synthetic Polymers Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global Cyanoacrylate Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global Cyanoacrylate Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global Cyanoacrylate Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global Polyethylene Glycol Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Global Polyethylene Glycol Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. Global Polyethylene Glycol Market Size, by Country, 2017-2032 (USD Million)
TABLE 98. Global Polyurethane Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Global Polyurethane Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. Global Polyurethane Market Size, by Country, 2017-2032 (USD Million)
TABLE 101. Global Surgical Hemostatic Material Market Size, by Form, 2017-2032 (USD Million)
TABLE 102. Global Foam Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Global Foam Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. Global Foam Market Size, by Country, 2017-2032 (USD Million)
TABLE 105. Global Injectable Flowable Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Global Injectable Flowable Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. Global Injectable Flowable Market Size, by Country, 2017-2032 (USD Million)
TABLE 108. Global Patch Gel And Film Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Global Patch Gel And Film Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. Global Patch Gel And Film Market Size, by Country, 2017-2032 (USD Million)
TABLE 111. Global Film Market Size, by Region, 2017-2032 (USD Million)
TABLE 112. Global Film Market Size, by Group, 2017-2032 (USD Million)
TABLE 113. Global Film Market Size, by Country, 2017-2032 (USD Million)
TABLE 114. Global Patch Market Size, by Region, 2017-2032 (USD Million)
TABLE 115. Global Patch Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. Global Patch Market Size, by Country, 2017-2032 (USD Million)
TABLE 117. Global Powder Market Size, by Region, 2017-2032 (USD Million)
TABLE 118. Global Powder Market Size, by Group, 2017-2032 (USD Million)
TABLE 119. Global Powder Market Size, by Country, 2017-2032 (USD Million)
TABLE 120. Global Ready To Use Market Size, by Region, 2017-2032 (USD Million)
TABLE 121. Global Ready To Use Market Size, by Group, 2017-2032 (USD Million)
TABLE 122. Global Ready To Use Market Size, by Country, 2017-2032 (USD Million)
TABLE 123. Global Requires Preparation Or Activation Market Size, by Region, 2017-2032 (USD Million)
TABLE 124. Global Requires Preparation Or Activation Market Size, by Group, 2017-2032 (USD Million)
TABLE 125. Global Requires Preparation Or Activation Market Size, by Country, 2017-2032 (USD Million)
TABLE 126. Global Sponge Market Size, by Region, 2017-2032 (USD Million)
TABLE 127. Global Sponge Market Size, by Group, 2017-2032 (USD Million)
TABLE 128. Global Sponge Market Size, by Country, 2017-2032 (USD Million)
TABLE 129. Global Ready To Use Market Size, by Region, 2017-2032 (USD Million)
TABLE 130. Global Ready To Use Market Size, by Group, 2017-2032 (USD Million)
TABLE 131. Global Ready To Use Market Size, by Country, 2017-2032 (USD Million)
TABLE 132. Global Requires Preparation Or Activation Market Size, by Region, 2017-2032 (USD Million)
TABLE 133. Global Requires Preparation Or Activation Market Size, by Group, 2017-2032 (USD Million)
TABLE 134. Global Requires Preparation Or Activation Market Size, by Country, 2017-2032 (USD Million)
TABLE 135. Global Spray Market Size, by Region, 2017-2032 (USD Million)
TABLE 136. Global Spray Market Size, by Group, 2017-2032 (USD Million)
TABLE 137. Global Spray Market Size, by Country, 2017-2032 (USD Million)
TABLE 138. Global Surgical Hemostatic Material Market Size, by Mode Of Action, 2017-2032 (USD Million)
TABLE 139. Global Active Coagulation Promotion Market Size, by Region, 2017-2032 (USD Million)
TABLE 140. Global Active Coagulation Promotion Market Size, by Group, 2017-2032 (USD Million)
TABLE 141. Global Active Coagulation Promotion Market Size, by Country, 2017-2032 (USD Million)
TABLE 142. Global Adsorption And Platelet Concentration Market Size, by Region, 2017-2032 (USD Million)
TABLE 143. Global Adsorption And Platelet Concentration Market Size, by Group, 2017-2032 (USD Million)
TABLE 144. Global Adsorption And Platelet Concentration Market Size, by Country, 2017-2032 (USD Million)
TABLE 145. Global Chemical Hemostatic Reaction Market Size, by Region, 2017-2032 (USD Million)
TABLE 146. Global Chemical Hemostatic Reaction Market Size, by Group, 2017-2032 (USD Million)
TABLE 147. Global Chemical Hemostatic Reaction Market Size, by Country, 2017-2032 (USD Million)
TABLE 148. Global Mechanical Tamponade Market Size, by Region, 2017-2032 (USD Million)
TABLE 149. Global Mechanical Tamponade Market Size, by Group, 2017-2032 (USD Million)
TABLE 150. Global Mechanical Tamponade Market Size, by Country, 2017-2032 (USD Million)
TABLE 151. Global Sealant And Barrier Formation Market Size, by Region, 2017-2032 (USD Million)
TABLE 152. Global Sealant And Barrier Formation Market Size, by Group, 2017-2032 (USD Million)
TABLE 153. Global Sealant And Barrier Formation Market Size, by Country, 2017-2032 (USD Million)
TABLE 154. Global Surgical Hemostatic Material Market Size, by End User, 2017-2032 (USD Million)
TABLE 155. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 156. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 157. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 158. Global Clinics And Outpatient Facilities Market Size, by Region, 2017-2032 (USD Million)
TABLE 159. Global Clinics And Outpatient Facilities Market Size, by Group, 2017-2032 (USD Million)
TABLE 160. Global Clinics And Outpatient Facilities Market Size, by Country, 2017-2032 (USD Million)
TABLE 161. Global Dental Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 162. Global Dental Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 163. Global Dental Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 164. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 165. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 166. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 167. Global Emergency And Trauma Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 168. Global Emergency And Trauma Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 169. Global Emergency And Trauma Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 170. Global Interventional Suites Market Size, by Region, 2017-2032 (USD Million)
TABLE 171. Global Interventional Suites Market Size, by Group, 2017-2032 (USD Million)
TABLE 172. Global Interventional Suites Market Size, by Country, 2017-2032 (USD Million)
TABLE 173. Global Operating Rooms Market Size, by Region, 2017-2032 (USD Million)
TABLE 174. Global Operating Rooms Market Size, by Group, 2017-2032 (USD Million)
TABLE 175. Global Operating Rooms Market Size, by Country, 2017-2032 (USD Million)
TABLE 176. Global Military And Field Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 177. Global Military And Field Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 178. Global Military And Field Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 179. Global Specialty Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 180. Global Specialty Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 181. Global Specialty Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 182. Global Surgical Hemostatic Material Market Size, by Application, 2017-2032 (USD Million)
TABLE 183. Global Cardiovascular Surgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 184. Global Cardiovascular Surgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 185. Global Cardiovascular Surgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 186. Global Cardiac Surgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 187. Global Cardiac Surgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 188. Global Cardiac Surgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 189. Global Vascular Surgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 190. Global Vascular Surgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 191. Global Vascular Surgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 192. Global Dental Procedures Market Size, by Region, 2017-2032 (USD Million)
TABLE 193. Global Dental Procedures Market Size, by Group, 2017-2032 (USD Million)
TABLE 194. Global Dental Procedures Market Size, by Country, 2017-2032 (USD Million)
TABLE 195. Global General Surgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 196. Global General Surgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 197. Global General Surgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 198. Global Gynecology Market Size, by Region, 2017-2032 (USD Million)
TABLE 199. Global Gynecology Market Size, by Group, 2017-2032 (USD Million)
TABLE 200. Global Gynecology Market Size, by Country, 2017-2032 (USD Million)
TABLE 201. Global Interventional And Endovascular Procedures Market Size, by Region, 2017-2032 (USD Million)
TABLE 202. Global Interventional And Endovascular Procedures Market Size, by Group, 2017-2032 (USD Million)
TABLE 203. Global Interventional And Endovascular Procedures Market Size, by Country, 2017-2032 (USD Million)
TABLE 204. Global Minimally Invasive And Laparoscopic Procedures Market Size, by Region, 2017-2032 (USD Million)
TABLE 205. Global Minimally Invasive And Laparoscopic Procedures Market Size, by Group, 2017-2032 (USD Million)
TABLE 206. Global Minimally Invasive And Laparoscopic Procedures Market Size, by Country, 2017-2032 (USD Million)
TABLE 207. Global Neurosurgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 208. Global Neurosurgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 209. Global Neurosurgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 210. Global Ophthalmic Surgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 211. Global Ophthalmic Surgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 212. Global Ophthalmic Surgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 213. Global Orthopedic Surgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 214. Global Orthopedic Surgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 215. Global Orthopedic Surgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 216. Global Joint Replacement Market Size, by Region, 2017-2032 (USD Million)
TABLE 217. Global Joint Replacement Market Size, by Group, 2017-2032 (USD Million)
TABLE 218. Global Joint Replacement Market Size, by Country, 2017-2032 (USD Million)
TABLE 219. Global Spine Surgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 220. Global Spine Surgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 221. Global Spine Surgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 222. Global Otolaryngology Market Size, by Region, 2017-2032 (USD Million)
TABLE 223. Global Otolaryngology Market Size, by Group, 2017-2032 (USD Million)
TABLE 224. Global Otolaryngology Market Size, by Country, 2017-2032 (USD Million)
TABLE 225. Global Plastic And Reconstructive Surgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 226. Global Plastic And Reconstructive Surgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 227. Global Plastic And Reconstructive Surgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 228. Global Trauma And Emergency Surgery Market Size, by Region, 2017-2032 (USD Million)
TABLE 229. Global Trauma And Emergency Surgery Market Size, by Group, 2017-2032 (USD Million)
TABLE 230. Global Trauma And Emergency Surgery Market Size, by Country, 2017-2032 (USD Million)
TABLE 231. Global Urology Market Size, by Region, 2017-2032 (USD Million)
TABLE 232. Global Urology Market Size, by Group, 2017-2032 (USD Million)
TABLE 233. Global Urology Market Size, by Country, 2017-2032 (USD Million)
TABLE 234. Global Surgical Hemostatic Material Market Size, by Region, 2017-2032 (USD Million)
TABLE 235. Asia-Pacific Surgical Hemostatic Material Market Size, by Region, 2017-2032 (USD Million)
TABLE 236. Asia-Pacific Surgical Hemostatic Material Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 237. Asia-Pacific Surgical Hemostatic Material Market Size, by Active Hemostats, 2017-2032 (USD Million)
TABLE 238. Asia-Pacific Surgical Hemostatic Material Market Size, by Passive Hemostats, 2017-2032 (USD Million)
TABLE 239. Asia-Pacific Surgical Hemostatic Material Market Size, by Sealants And Adhesives, 2017-2032 (USD Million)
TABLE 240. Asia-Pacific Surgical Hemostatic Material Market Size, by Composition, 2017-2032 (USD Million)
TABLE 241. Asia-Pacific Surgical Hemostatic Material Market Size, by Biological Components, 2017-2032 (USD Million)
TABLE 242. Asia-Pacific Surgical Hemostatic Material Market Size, by Natural Polymers, 2017-2032 (USD Million)
TABLE 243. Asia-Pacific Surgical Hemostatic Material Market Size, by Synthetic Polymers, 2017-2032 (USD Million)
TABLE 244. Asia-Pacific Surgical Hemostatic Material Market Size, by Form, 2017-2032 (USD Million)
TABLE 245. Asia-Pacific Surgical Hemostatic Material Market Size, by Patch Gel And Film, 2017-2032 (USD Million)
TABLE 246. Asia-Pacific Surgical Hemostatic Material Market Size, by Powder, 2017-2032 (USD Million)
TABLE 247. Asia-Pacific Surgical Hemostatic Material Market Size, by Sponge, 2017-2032 (USD Million)
TABLE 248. Asia-Pacific Surgical Hemostatic Material Market Size, by Mode Of Action, 2017-2032 (USD Million)
TABLE 249. Asia-Pacific Surgical Hemostatic Material Market Size, by End User, 2017-2032 (USD Million)
TABLE 250. Asia-Pacific Surgical Hemostatic Material Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 251. Asia-Pacific Surgical Hemostatic Material Market Size, by Application, 2017-2032 (USD Million)
TABLE 252. Asia-Pacific Surgical Hemostatic Material Market Size, by Cardiovascular Surgery, 2017-2032 (USD Million)
TABLE 253. Asia-Pacific Surgical Hemostatic Material Market Size, by Orthopedic Surgery, 2017-2032 (USD Million)
TABLE 254. North America Surgical Hemostatic Material Market Size, by Region, 2017-2032 (USD Million)
TABLE 255. North America Surgical Hemostatic Material Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 256. North America Surgical Hemostatic Material Market Size, by Active Hemostats, 2017-2032 (USD Million)
TABLE 257. North America Surgical Hemostatic Material Market Size, by Passive Hemostats, 2017-2032 (USD Million)
TABLE 258. North America Surgical Hemostatic Material Market Size, by Sealants And Adhesives, 2017-2032 (USD Million)
TABLE 259. North America Surgical Hemostatic Material Market Size, by Composition, 2017-2032 (USD Million)
TABLE 260. North America Surgical Hemostatic Material Market Size, by Biological Components, 2017-2032 (USD Million)
TABLE 261. North America Surgical Hemostatic Material Market Size, by Natural Polymers, 2017-2032 (USD Million)
TABLE 262. North America Surgical Hemostatic Material Market Size, by Synthetic Polymers, 2017-2032 (USD Million)
TABLE 263. North America Surgical Hemostatic Material Market Size, by Form, 2017-2032 (USD Million)
TABLE 264. North America Surgical Hemostatic Material Market Size, by Patch Gel And Film, 2017-2032 (USD Million)
TABLE 265. North America Surgical Hemostatic Material Market Size, by Powder, 2017-2032 (USD Million)
TABLE 266. North America Surgical Hemostatic Material Market Size, by Sponge, 2017-2032 (USD Million)
TABLE 267. North America Surgical Hemostatic Material Market Size, by Mode Of Action, 2017-2032 (USD Million)
TABLE 268. North America Surgical Hemostatic Material Market Size, by End User, 2017-2032 (USD Million)
TABLE 269. North America Surgical Hemostatic Material Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 270. North America Surgical Hemostatic Material Market Size, by Application, 2017-2032 (USD Million)
TABLE 271. North America Surgical Hemostatic Material Market Size, by Cardiovascular Surgery, 2017-2032 (USD Million)
TABLE 272. North America Surgical Hemostatic Material Market Size, by Orthopedic Surgery, 2017-2032 (USD Million)
TABLE 273. Latin America Surgical Hemostatic Material Market Size, by Region, 2017-2032 (USD Million)
TABLE 274. Latin America Surgical Hemostatic Material Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 275. Latin America Surgical Hemostatic Material Market Size, by Active Hemostats, 2017-2032 (USD Million)
TABLE 276. Latin America Surgical Hemostatic Material Market Size, by Passive Hemostats, 2017-2032 (USD Million)
TABLE 277. Latin America Surgical Hemostatic Material Market Size, by Sealants And Adhesives, 2017-2032 (USD Million)
TABLE 278. Latin America Surgical Hemostatic Material Market Size, by Composition, 2017-2032 (USD Million)
TABLE 279. Latin America Surgical Hemostatic Material Market Size, by Biological Components, 2017-2032 (USD Million)
TABLE 280. Latin America Surgical Hemostatic Material Market Size, by Natural Polymers, 2017-2032 (USD Million)
TABLE 281. Latin America Surgical Hemostatic Material Market Size, by Synthetic Polymers, 2017-2032 (USD Million)
TABLE 282. Latin America Surgical Hemostatic Material Market Size, by Form, 2017-2032 (USD Million)
TABLE 283. Latin America Surgical Hemostatic Material Market Size, by Patch Gel And Film, 2017-2032 (USD Million)
TABLE 284. Latin America Surgical Hemostatic Material Market Size, by Powder, 2017-2032 (USD Million)
TABLE 285. Latin America Surgical Hemostatic Material Market Size, by Sponge, 2017-2032 (USD Million)
TABLE 286. Latin America Surgical Hemostatic Material Market Size, by Mode Of Action, 2017-2032 (USD Million)
TABLE 287. Latin America Surgical Hemostatic Material Market Size, by End User, 2017-2032 (USD Million)
TABLE 288. Latin America Surgical Hemostatic Material Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 289. Latin America Surgical Hemostatic Material Market Size, by Application, 2017-2032 (USD Million)
TABLE 290. Latin America Surgical Hemostatic Material Market Size, by Cardiovascular Surgery, 2017-2032 (USD Million)
TABLE 291. Latin America Surgical Hemostatic Material Market Size, by Orthopedic Surgery, 2017-2032 (USD Million)
TABLE 292. Europe Surgical Hemostatic Material Market Size, by Region, 2017-2032 (USD Million)
TABLE 293. Europe Surgical Hemostatic Material Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 294. Europe Surgical Hemostatic Material Market Size, by Active Hemostats, 2017-2032 (USD Million)
TABLE 295. Europe Surgical Hemostatic Material Market Size, by Passive Hemostats, 2017-2032 (USD Million)
TABLE 296. Europe Surgical Hemostatic Material Market Size, by Sealants And Adhesives, 2017-2032 (USD Million)
TABLE 297. Europe Surgical Hemostatic Material Market Size, by Composition, 2017-2032 (USD Million)
TABLE 298. Europe Surgical Hemostatic Material Market Size, by Biological Components, 2017-2032 (USD Million)
TABLE 299. Europe Surgical Hemostatic Material Market Size, by Natural Polymers, 2017-2032 (USD Million)
TABLE 300. Europe Surgical Hemostatic Material Market Size, by Synthetic Polymers, 2017-2032 (USD Million)
TABLE 301. Europe Surgical Hemostatic Material Market Size, by Form, 2017-2032 (USD Million)
TABLE 302. Europe Surgical Hemostatic Material Market Size, by Patch Gel And Film, 2017-2032 (USD Million)
TABLE 303. Europe Surgical Hemostatic Material Market Size, by Powder, 2017-2032 (USD Million)
TABLE 304. Europe Surgical Hemostatic Material Market Size, by Sponge, 2017-2032 (USD Million)
TABLE 305. Europe Surgical Hemostatic Material Market Size, by Mode Of Action, 2017-2032 (USD Million)
TABLE 306. Europe Surgical Hemostatic Material Market Size, by End User, 2017-2032 (USD Million)
TABLE 307. Europe Surgical Hemostatic Material Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 308. Europe Surgical Hemostatic Material Market Size, by Application, 2017-2032 (USD Million)
TABLE 309. Europe Surgical Hemostatic Material Market Size, by Cardiovascular Surgery, 2017-2032 (USD Million)
TABLE 310. Europe Surgical Hemostatic Material Market Size, by Orthopedic Surgery, 2017-2032 (USD Million)
TABLE 311. Middle East Surgical Hemostatic Material Market Size, by Region, 2017-2032 (USD Million)
TABLE 312. Middle East Surgical Hemostatic Material Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 313. Middle East Surgical Hemostatic Material Market Size, by Active Hemostats, 2017-2032 (USD Million)
TABLE 314. Middle East Surgical Hemostatic Material Market Size, by Passive Hemostats, 2017-2032 (USD Million)
TABLE 315. Middle East Surgical Hemostatic Material Market Size, by Sealants And Adhesives, 2017-2032 (USD Million)
TABLE 316. Middle East Surgical Hemostatic Material Market Size, by Composition, 2017-2032 (USD Million)
TABLE 317. Middle East Surgical Hemostatic Material Market Size, by Biological Components, 2017-2032 (USD Million)
TABLE 318. Middle East Surgical Hemostatic Material Market Size, by Natural Polymers, 2017-2032 (USD Million)
TABLE 319. Middle East Surgical Hemostatic Material Market Size, by Synthetic Polymers, 2017-2032 (USD Million)
TABLE 320. Middle East Surgical Hemostatic Material Market Size, by Form, 2017-2032 (USD Million)
TABLE 321. Middle East Surgical Hemostatic Material Market Size, by Patch Gel And Film, 2017-2032 (USD Million)
TABLE 322. Middle East Surgical Hemostatic Material Market Size, by Powder, 2017-2032 (USD Million)
TABLE 323. Middle East Surgical Hemostatic Material Market Size, by Sponge, 2017-2032 (USD Million)
TABLE 324. Middle East Surgical Hemostatic Material Market Size, by Mode Of Action, 2017-2032 (USD Million)
TABLE 325. Middle East Surgical Hemostatic Material Market Size, by End User, 2017-2032 (USD Million)
TABLE 326. Middle East Surgical Hemostatic Material Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 327. Middle East Surgical Hemostatic Material Market Size, by Application, 2017-2032 (USD Million)
TABLE 328. Middle East Surgical Hemostatic Material Market Size, by Cardiovascular Surgery, 2017-2032 (USD Million)
TABLE 329. Middle East Surgical Hemostatic Material Market Size, by Orthopedic Surgery, 2017-2032 (USD Million)
TABLE 330. Africa Surgical Hemostatic Material Market Size, by Region, 2017-2032 (USD Million)
TABLE 331. Africa Surgical Hemostatic Material Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 332. Africa Surgical Hemostatic Material Market Size, by Active Hemostats, 2017-2032 (USD Million)
TABLE 333. Africa Surgical Hemostatic Material Market Size, by Passive Hemostats, 2017-2032 (USD Million)
TABLE 334. Africa Surgical Hemostatic Material Market Size, by Sealants And Adhesives, 2017-2032 (USD Million)
TABLE 335. Africa Surgical Hemostatic Material Market Size, by Composition, 2017-2032 (USD Million)
TABLE 336. Africa Surgical Hemostatic Material Market Size, by Biological Components, 2017-2032 (USD Million)
TABLE 337. Africa Surgical Hemostatic Material Market Size, by Natural Polymers, 2017-2032 (USD Million)
TABLE 338. Africa Surgical Hemostatic Material Market Size, by Synthetic Polymers, 2017-2032 (USD Million)
TABLE 339. Africa Surgical Hemostatic Material Market Size, by Form, 2017-2032 (USD Million)
TABLE 340. Africa Surgical Hemostatic Material Market Size, by Patch Gel And Film, 2017-2032 (USD Million)
TABLE 341. Africa Surgical Hemostatic Material Market Size, by Powder, 2017-2032 (USD Million)
TABLE 342. Africa Surgical Hemostatic Material Market Size, by Sponge, 2017-2032 (USD Million)
TABLE 343. Africa Surgical Hemostatic Material Market Size, by Mode Of Action, 2017-2032 (USD Million)
TABLE 344. Africa Surgical Hemostatic Material Market Size, by End User, 2017-2032 (USD Million)
TABLE 345. Africa Surgical Hemostatic Material Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 346. Africa Surgical Hemostatic Material Market Size, by Application, 2017-2032 (USD Million)
TABLE 347. Africa Surgical Hemostatic Material Market Size, by Cardiovascular Surgery, 2017-2032 (USD Million)
TABLE 348. Africa Surgical Hemostatic Material Market Size, by Orthopedic Surgery, 2017-2032 (USD Million)
TABLE 349. Global Surgical Hemostatic Material Market Size, by Group, 2017-2032 (USD Million)
TABLE 350. ASEAN Surgical Hemostatic Material Market Size, by Group, 2017-2032 (USD Million)
TABLE 351. ASEAN Surgical Hemostatic Material Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 352. ASEAN Surgical Hemostatic Material Market Size, by Active Hemostats, 2017-2032 (USD Million)
TABLE 353. ASEAN Surgical Hemostatic Material Market Size, by Passive Hemostats, 2017-2032 (USD Million)
TABLE 354. ASEAN

Companies Mentioned

  • Aegis Lifesciences Private Limited
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • CryoLife, Inc.
  • Ferrosan Medical Devices A/S
  • Hangzhou Singclean Medical Products Co., Ltd.
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson
  • Medtronic plc
  • Smith & Nephew plc
  • Stryker Corporation
  • Takeda Pharmaceutical Company Limited

Related Topics

Related Reports

Topical hemostatic Product Market - Global Forecast 2026-2032 - Product Image

Topical hemostatic Product Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Chitosan Hemostatic Material Market - Global Forecast 2026-2032 - Product Image

Chitosan Hemostatic Material Market - Global Forecast 2026-2032

  • Report
  • 190 Pages
  • Global
From
Flowable Hemostats Market - Global Forecast 2026-2032 - Product Image

Flowable Hemostats Market - Global Forecast 2026-2032

  • Report
  • 185 Pages
  • Global
From
Hemostats Patent Landscape Report - Product Image

Hemostats Patent Landscape Report

  • Report
  • 200 Pages
  • Global
From
Absorbable Collagen Hemostatic Sponge Market - Global Forecast 2026-2032 - Product Image

Absorbable Collagen Hemostatic Sponge Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.